SRIPLAW opened for business in Boca Raton, Florida on January 1, 2013.  We started the firm in order to work with clients that we felt had strong claims but could not get quality representation elsewhere.  

Alibaba.com is the world's largest online business to business (B2B) marketplace.  If you are a creator, designer, inventor, product marketer, brand builder, or anyone else interested in global commerce or trade in consumer goods, you have probably either purchased from sellers on Alibaba.com,

Taking a patent infringement case on contingency requires skills and experience in many areas, but two are key: determining infringement and analyzing damages.  The investment of time, energy and resources in a contingency case can be substantial.  

The Supreme Court's decision invalidating a software patent for a process that lessens settlement risk for trades of financial instruments in Alice Corp. Pty. Ltd. v.

Schneider Rothman partner and patent guru Jerold I. Schneider was recently featured on Gene Quinn's well read blog IPWatchdog.com discussing design patent infringement.  In his article, Jerry discusses why design patents have the potential to create value for patentees since the Federal Circuit simplified the standard for proving infringement on the ornamental features of a product in the Egyptian Goddess case.

Design patents are misunderstood and under-utilized.  But that is changing.  The last few years have seen a significant shift, favoring the design patent owner, on evaluating design patent infringement. 

Examination of Patent Applications at the United States Patent and Trademark Office (USPTO or PTO) takes too long.  That's the message from the USPTO’s own Performance and Accountability Report for Fiscal Year 2013.

Section 102(b) of the U.S. Patent Act prevents an inventor from getting a patent for an invention that was “described in a printed publication in this .

Trade secret and patent protection for nutraceuticals. Can't get more current than that. And three lawyers from Foley & Lardner provide info on both in a pair of articles published in the last week or so.

This article entitled "Preserving intellectual property before a patent is issued" provides an excellent overview of the patent protection available to neutraceutical companies. The authors, James F.

Archer Daniels Midland a/k/a "supermarket to the world" has sued Sabinsa Corporation, a maker of nutritional ingredients, for patent infringement related to patents that ADM licenses from Novogen.

The Original Creatine Patent Company, a UK firm that owns several patents for creatine supplement formulations, has sued NBTY and several of its subsidiaries, including Vitamin World, Nature's Bounty, and Puritan's Pride, for patent infringement.

While nutritional supplement patents are not unheard of, it is still somewhat unusual for nutritional supplement makers to apply for patents on their formulations. Instead, supplement makers typically rely on trade secret protection, creating proprietary blends of ingredients and keeping the formula secret.

This article titled Big problem for BioStratum describes how the active ingredient in this company's drug (now in Phase II trials) is available for purchase on the Internet as a nutritional supplement.